Renal dialysis

Global Extracorporeal Circuit of Hemodialysis Market to 2025 - by Manufacturers, Regions, Technology, and Product Type

Retrieved on: 
Friday, November 13, 2020
Medicine, Membrane technology, Renal dialysis, Natural sciences, Hemodialysis, Extracorporeal, Dialysis

DUBLIN, Nov. 13, 2020 /PRNewswire/ -- The "Extracorporeal Circuit of Hemodialysis Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Product Type" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 13, 2020 /PRNewswire/ -- The "Extracorporeal Circuit of Hemodialysis Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Product Type" report has been added to ResearchAndMarkets.com's offering.
  • This report is a professional and in-depth study on the current state of the global Extracorporeal Circuit of Hemodialysis market with a focus on the Chinese market.
  • The global Extracorporeal Circuit of Hemodialysis market is further divided by company, by country, and by application/type for the competitive landscape analysis.
  • Overall, the report provides an in-depth insight of 2015-2025 global and Chinese Extracorporeal Circuit of Hemodialysis market covering all important parameters.

Worldwide Extracorporeal Circuit of Hemodialysis Industry to 2025 - Featuring Baxter, Fresenius & Ningbo Tianyi Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, November 6, 2020
Medical devices, Health, Medicine, Membrane technology, Natural sciences, Renal dialysis, Hemodialysis, Extracorporeal, Dialysis

Key points of Extracorporeal Circuit of Hemodialysis Market Report:

Key Points: 
  • Key points of Extracorporeal Circuit of Hemodialysis Market Report:
    The report provides a basic overview of Extracorporeal Circuit of Hemodialysis industry including: definition, applications and manufacturing technology.
  • The report explores Global and Chinese major players in Extracorporeal Circuit of Hemodialysis market.
  • The global Extracorporeal Circuit of Hemodialysis market is further divided by company, by country, and by application/type for the competitive landscape analysis.
  • Overall, the report provides an in-depth insight of 2015-2025 global and Chinese Extracorporeal Circuit of Hemodialysis market covering all important parameters.

Dialysis Patient Citizens and Consumers' Checkbook Introduce Dialysis Plan Choice To Help Patients During Open Enrollment

Retrieved on: 
Monday, November 2, 2020
Renal dialysis, Medicine, Clinical medicine, Health care, Dialysis Patient Citizens, Membrane technology, Dialysis, Medicare, Home hemodialysis

WASHINGTON, Nov. 2,2020 /PRNewswire/ --Dialysis Patient Citizens (DPC) today introduced Dialysis Plan Choice, a new onlinetooldesigned in collaboration with Consumers' Checkbookfor dialysispatients to quickly and easily compare their current Medicare Fee-For-Service plan with the options available to them through Medicare Advantagenow that Open Enrollment is underway.

Key Points: 
  • WASHINGTON, Nov. 2,2020 /PRNewswire/ --Dialysis Patient Citizens (DPC) today introduced Dialysis Plan Choice, a new onlinetooldesigned in collaboration with Consumers' Checkbookfor dialysispatients to quickly and easily compare their current Medicare Fee-For-Service plan with the options available to them through Medicare Advantagenow that Open Enrollment is underway.
  • This way, all patients can make an informed decision about what plans are best for themselves and their families."
  • For more information,please visit www.DialysisPlanChoice.org and learn more about the issues affecting dialysis patients at www.dialysispatients.org .
  • Dialysis Patient Citizens is a patient-led, national, non-profit organization dedicated to improving the quality of life for all dialysis patients by advocating for favorable public policy.

Minimally Invasive Ellipsys System Creates Fused, Permanent Vascular Access for Dialysis

Retrieved on: 
Friday, October 30, 2020
Medicine, Clinical medicine, Medical specialties, Renal dialysis, Vascular access, Vascular surgery, Hemodialysis, Fistula, Arteriovenous, Catheter, Cimino fistula, Interventional radiology

SAN JUAN CAPISTRANO, Calif., Oct. 30, 2020 /PRNewswire/ --A new case report published in the Journal of Vascular Surgery provides one of the first known opportunities to directly visualize the permanent and fused connection (anastomosis) that is created with the minimally invasive Ellipsys Vascular Access System.

Key Points: 
  • SAN JUAN CAPISTRANO, Calif., Oct. 30, 2020 /PRNewswire/ --A new case report published in the Journal of Vascular Surgery provides one of the first known opportunities to directly visualize the permanent and fused connection (anastomosis) that is created with the minimally invasive Ellipsys Vascular Access System.
  • The Ellipsys System, made by Avenu Medical, creates a type of dialysis access known as a percutaneous arteriovenous fistula (pAVF) for patients with end-stage renal disease (ESRD) who require hemodialysis.
  • Dr. Mallios has published numerous studies showing the ability of the Ellipsys System to easily and safely create durable vascular access for ESRD patients.
  • The company's Ellipsys Vascular Access System is an innovative, ultrasound-guided, single-catheter endoAVF system used to percutaneously create an arteriovenous fistula for hemodialysis access.

Hemodialysis and Peritoneal Dialysis Market Worth $17.69 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®

Retrieved on: 
Tuesday, October 27, 2020
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Peritoneal dialysis, Dialysis, Hemodialysis, Peritoneum, Kt/V, Northwest Kidney Centers

In peritoneal dialysis, the patient's peritoneum in the abdomen acts as a membrane across which fluids and dissolved substances are exchanged from the blood.

Key Points: 
  • In peritoneal dialysis, the patient's peritoneum in the abdomen acts as a membrane across which fluids and dissolved substances are exchanged from the blood.
  • Due to lockdowns, the availability of consumables and equipment for hemodialysis and peritoneal dialysis and essential medicines has been affected.
  • Based on end user, hospitals, clinics, and dialysis centers are estimated to command the largest share of the overall hemodialysis and peritoneal dialysis market in 2020.
  • Geographically, North America is estimated to dominate the global hemodialysis and peritoneal dialysis market in 2020, followed by Europe and Asia-Pacific.

Hemodialysis and Peritoneal Dialysis Market Worth $17.69 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®

Retrieved on: 
Tuesday, October 27, 2020
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Peritoneal dialysis, Dialysis, Hemodialysis, Peritoneum, Kt/V, Northwest Kidney Centers

In peritoneal dialysis, the patient's peritoneum in the abdomen acts as a membrane across which fluids and dissolved substances are exchanged from the blood.

Key Points: 
  • In peritoneal dialysis, the patient's peritoneum in the abdomen acts as a membrane across which fluids and dissolved substances are exchanged from the blood.
  • Due to lockdowns, the availability of consumables and equipment for hemodialysis and peritoneal dialysis and essential medicines has been affected.
  • Based on end user, hospitals, clinics, and dialysis centers are estimated to command the largest share of the overall hemodialysis and peritoneal dialysis market in 2020.
  • Geographically, North America is estimated to dominate the global hemodialysis and peritoneal dialysis market in 2020, followed by Europe and Asia-Pacific.

Rockwell Medical to Report Third Quarter 2020 Financial and Operating Results on November 9, 2020

Retrieved on: 
Tuesday, October 27, 2020
Medicine, Membrane technology, Clinical medicine, Renal dialysis, Rockwell Medical, Dialysis, Hemodialysis

ET to discuss its financial results for the three months ended September 30, 2020, and recent operational highlights.

Key Points: 
  • ET to discuss its financial results for the three months ended September 30, 2020, and recent operational highlights.
  • A live webcast of the call will be available under "Events & Presentations" in the Investor section of the Company's website, https://ir.rockwellmed.com/.
  • An archived webcast will be available on the Company's website approximately two hours after the event and will be available for 30 days.
  • Rockwell Medical is also an established manufacturer, supplier and leader in delivering high-quality hemodialysis concentrates/dialysates to dialysis providers and distributors in the U.S. and abroad.

Akebia Presents Results from its INNO2VATE Global Phase 3 Program; Demonstrated Efficacy and Cardiovascular Safety of Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis

Retrieved on: 
Thursday, October 22, 2020
Medicine, Clinical medicine, Medical specialties, Membrane technology, Renal dialysis, Kidney diseases, Erythropoiesis-stimulating agents, Acetic acids, Dialysis, Epoetin alfa, Vadadustat, Chronic kidney disease

"The data presented today build on the positive top-line efficacy and safety results from INNO2VATE that were previously reported in May.

Key Points: 
  • "The data presented today build on the positive top-line efficacy and safety results from INNO2VATE that were previously reported in May.
  • The INNO2VATE results demonstrate that vadadustat could represent an attractive new oral treatment option for patients new to and already established on dialysis, upon approval."
  • Results from INNO2VATE are being presented today atASN Kidney Week during a presentation titled, "Global Phase 3 Clinical Trials of Vadadustat vs Darbepoetin Alfa for Treatment of Anemia in Patients with Dialysis-Dependent Chronic Kidney Disease"(Abstract TH-OR01).
  • The INNO2VATE incident dialysis patient study evaluated 369 incident dialysis patients and the prevalent dialysis study evaluated 3,554 prevalent dialysis patients.

New Data Offers Insights on Treatment with KRYSTEXXA® (pegloticase injection) Among Kidney Transplant Patients for the Management of Uncontrolled Gout

Retrieved on: 
Thursday, October 22, 2020
Biotechnology, Pharmaceutical, Health, Clinical trials, Clinical medicine, Medicine, Medical specialties, Renal dialysis, Membrane technology, Dialysis, Hemodialysis, Kidney transplantation, Organ transplantation, Peritoneal dialysis, Northwest Kidney Centers, Autosomal dominant polycystic kidney disease, KRYSTEXXA, Horizon

Early data of this ongoing clinical trial are encouraging and suggest KRYSTEXXA is safe and effective for treating uncontrolled gout in this very sensitive transplant population without compromising kidney function.

Key Points: 
  • Early data of this ongoing clinical trial are encouraging and suggest KRYSTEXXA is safe and effective for treating uncontrolled gout in this very sensitive transplant population without compromising kidney function.
  • Of the 136 patients reviewed, 77 patients received KRYSTEXXA following ERSD and 42 of the 77 patients underwent routine dialysis while receiving KRYSTEXXA.
  • Seven patients were donor kidney recipients, and more patients were undergoing hemodialysis (76 percent) than peritoneal dialysis (24 patients).
  • Study of Pegloticase in Patients with Uncontrolled Gout Who Have Had a Kidney Transplant (PROTECT).

2020 Hemodialysis Catheters Pipeline Insight and Competitive Landscape: Comprehensive Insights on 15 Companies & Drug Profiles - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 20, 2020
Retail, Other Retail, Catheters, Medicine, Clinical medicine, Medical equipment, Membrane technology, Renal dialysis, Venous access, Hemodialysis, Dialysis catheter, Peripheral venous catheter, Dialysis, Port

The "Hemodialysis Catheters Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemodialysis Catheters Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The "Hemodialysis Catheters - Pipeline Insight and Competitive Landscape, 2020," report provides comprehensive insights about 15+ companies and 15+ pipeline devices in Hemodialysis Catheters pipeline landscape.
  • 15+ key companies which are developing the products for Hemodialysis Catheters.
  • Access Vascular is developing a comprehensive suite of venous access devices, including peripheral venous catheters, dialysis catheter and ports.